IDEXX Laboratories Inc (IDXX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IDEXX Laboratories Inc (IDXX) has a cash flow conversion efficiency ratio of 0.215x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($347.16 Million) by net assets ($1.61 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is IDEXX Laboratories Inc worth for the company's overall valuation and market capitalisation.
IDEXX Laboratories Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how IDEXX Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
IDEXX Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IDEXX Laboratories Inc ranked by their cash flow conversion efficiency. Explore IDXX cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Block, Inc
NYSE:XYZ
|
0.045x |
|
ASSA ABLOY AB (publ)
ST:ASSA-B
|
0.073x |
|
Haleon plc
NYSE:HLN
|
0.055x |
|
Paychex Inc
NASDAQ:PAYX
|
0.156x |
|
Ferrovial SE
NASDAQ:FER
|
0.106x |
|
Flex Ltd
F:FXI
|
0.080x |
|
Waste Connections Inc
TO:WCN
|
0.293x |
|
Ameriprise Financial Inc
NYSE:AMP
|
0.074x |
Annual Cash Flow Conversion Efficiency for IDEXX Laboratories Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of IDEXX Laboratories Inc from 1991 to 2025. View today's stock price for IDEXX Laboratories Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.61 Billion | $1.18 Billion | 0.734x | +26.01% |
| 2024-12-31 | $1.60 Billion | $929.00 Million | 0.582x | -4.64% |
| 2023-12-31 | $1.48 Billion | $906.51 Million | 0.611x | -31.54% |
| 2022-12-31 | $608.74 Million | $542.98 Million | 0.892x | -18.54% |
| 2021-12-31 | $689.99 Million | $755.55 Million | 1.095x | +6.92% |
| 2020-12-31 | $632.79 Million | $648.06 Million | 1.024x | -60.34% |
| 2019-12-31 | $177.82 Million | $459.16 Million | 2.582x | +105.96% |
| 2018-12-31 | $-9.23 Million | $400.08 Million | -43.332x | -525.03% |
| 2017-12-31 | $-53.84 Million | $373.28 Million | -6.933x | -124.23% |
| 2016-12-31 | $-108.21 Million | $334.57 Million | -3.092x | -20.03% |
| 2015-12-31 | $-84.00 Million | $216.36 Million | -2.576x | -228.43% |
| 2014-12-31 | $117.59 Million | $235.85 Million | 2.006x | +322.52% |
| 2013-12-31 | $518.21 Million | $246.00 Million | 0.475x | +31.16% |
| 2012-12-31 | $636.26 Million | $230.28 Million | 0.362x | -11.51% |
| 2011-12-31 | $539.59 Million | $220.70 Million | 0.409x | +31.34% |
| 2010-12-31 | $574.28 Million | $178.83 Million | 0.311x | -7.76% |
| 2009-12-31 | $514.58 Million | $173.72 Million | 0.338x | +3.20% |
| 2008-12-31 | $438.19 Million | $143.34 Million | 0.327x | +6.11% |
| 2007-12-31 | $438.32 Million | $135.12 Million | 0.308x | +15.05% |
| 2006-12-31 | $409.86 Million | $109.83 Million | 0.268x | -15.09% |
| 2005-12-31 | $369.31 Million | $116.55 Million | 0.316x | +31.58% |
| 2004-12-31 | $397.66 Million | $95.38 Million | 0.240x | -15.39% |
| 2003-12-31 | $413.29 Million | $117.16 Million | 0.283x | -6.39% |
| 2002-12-31 | $340.97 Million | $103.25 Million | 0.303x | +97.07% |
| 2001-12-31 | $301.73 Million | $46.36 Million | 0.154x | +42.42% |
| 2000-12-31 | $261.75 Million | $28.24 Million | 0.108x | -41.69% |
| 1999-12-31 | $284.30 Million | $52.60 Million | 0.185x | +23.53% |
| 1998-12-31 | $307.80 Million | $46.10 Million | 0.150x | +235.82% |
| 1997-12-31 | $302.70 Million | $13.50 Million | 0.045x | +79.90% |
| 1996-12-31 | $322.70 Million | $8.00 Million | 0.025x | +1.75% |
| 1995-12-31 | $279.10 Million | $6.80 Million | 0.024x | -83.57% |
| 1994-12-31 | $99.80 Million | $14.80 Million | 0.148x | +67.54% |
| 1993-12-31 | $83.60 Million | $7.40 Million | 0.089x | +6331.58% |
| 1992-12-31 | $70.40 Million | $-100.00K | -0.001x | -101.18% |
| 1991-12-31 | $31.50 Million | $3.80 Million | 0.121x | -- |
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urin… Read more